Browse All
Displaying 181 - 185 of 1694
Author:Furr Stimming, Erin Claassen, Daniel Kayson, Elise Goldstein, Jody Hinton, Sean Klepitskaya, Olga Zhang, Hui Liang, Grace Haubenberger, Dietrich
Session Name:S30: Movement Disorders: Clinical Trials in Movement Disorders
Topic:Movement Disorders
Program Number:S30.003
Author Institution:The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX Vanderbilt University Medical Center, Nashville, TN Huntington Study Group®, Rochester, NY Neurocrine Biosciences, Inc., San Diego, CA
Author:deMarcaida, Joy Antonelle Litman, Pninit Friedman, Hadas Fitzer-Attas, Cheryl
Program Number:S30.004
Author Institution:Hartford HealthCare Chase Family Movement Disorders Center, Vernon, CT Pharma Two B, Rehovot, Israel Pharma Two B, Dayton, NJ
Author:Henchcliffe, Claire Ma, Yilong Sarva, Harini Lozano, Andres Fasano, Alfonso Kalia, Suneil Yu, Kenny Kwok Hei Brennan, Cameron Jennings, Nicki stemple, Whitney Abid, Nauman Yountz, Marcus Enayetallah, Ahmed Lampron, Antoine Tabar, Viviane Eidelberg, David
Program Number:S30.005
Author Institution:University of California, Irvine, Orange, CA Feinstein Institute for Medical Research, Manhasset, NY Weill Cornell Medical Center, New York, NY Toronto Western Hosp, Toronto, ON, Canada Toronto Western Hospital - U of Toronto, Toronto, ON, Canada University of Toronto, Toronto, ON, Canada Memorial Sloan Kettering Cancer Center, New York, NY BlueRock Therapeutics LP, Cambridge, MA BlueRock Therapeutics, Cambridge, MA
Author:Pagano, Gennaro Monnet, Annabelle Reyes, Adriana Simuni, Tanya Postuma, Ronald Pavese, Nicola Stocchi, Fabrizio Smigorski, Krzysztof Gerbaldo, Valentina Thomas, Riorge Svoboda, Hanno Fontoura, Paulo Doody, Rachelle Kerchner, Geoffrey Brundin, Patrik Bonni, Azad Marek, Kenneth Nikolcheva, Tania
Program Number:S30.006
Author Institution:Roche Pharma Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland F. Hoffmann-La Roche Ltd, Basel, Switzerland Northwestern University Feinberg School of Medicine, Chicago, IL Montreal General Hospital, Montreal, QC, Canada Newcastle University, Newcastle upon Tyne, England, United Kingdom Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy Excelya Germany GmbH, 78462, Germany Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom Roche Diagnostics GmbH, DE, Basel, Switzerland Invicro, A Konica Minolta Company, New Haven, CT
Author:Wong, Ka-Ho Marini, Erica Francis, Trieste Kadish, Robert Galli, Jonathan Paz Soldan, M. Klein, Julia Sorenson, Abigail King, Jordan Rose, John Smith, Tammy Clardy, Stacey
Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making
Topic:Multiple Sclerosis
Program Number:S31.001
Author Institution:U of U Neurology Clinic, Salt Lake City, UT University of Utah, Salt Lake City, UT University of Utah School of Medicine, Salt Lake City, UT UC Berkeley, Berkeley, CA Imaging and Neurosciences Center, Salt Lake City, UT
